Endo Aims To Stabilize Generics Unit In 2021

Company Delivers Another Underwhelming Quarter

 
• By Akriti Seth
  
competition
Endo expects to see additional competition on its “higher revenue products” in 2021 • Source: Shutterstock

More from Strategy

More from Business